Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $9.8 billion.

  • Sanofi's Receivables - Net rose 1934.38% to $9.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.8 billion, marking a year-over-year increase of 1934.38%. This contributed to the annual value of $9.5 billion for FY2025, which is 1438.24% up from last year.
  • Per Sanofi's latest filing, its Receivables - Net stood at $9.8 billion for Q4 2025, which was up 1934.38% from $8.8 billion recorded in Q2 2025.
  • Sanofi's Receivables - Net's 5-year high stood at $9.8 billion during Q4 2025, with a 5-year trough of $8.2 billion in Q2 2021.
  • For the 5-year period, Sanofi's Receivables - Net averaged around $8.8 billion, with its median value being $8.7 billion (2021).
  • Per our database at Business Quant, Sanofi's Receivables - Net plummeted by 958.62% in 2024 and then skyrocketed by 1934.38% in 2025.
  • Sanofi's Receivables - Net (Quarter) stood at $8.7 billion in 2021, then decreased by 0.73% to $8.6 billion in 2022, then rose by 5.57% to $9.1 billion in 2023, then dropped by 9.59% to $8.2 billion in 2024, then increased by 19.34% to $9.8 billion in 2025.
  • Its Receivables - Net stands at $9.8 billion for Q4 2025, versus $8.8 billion for Q2 2025 and $8.2 billion for Q4 2024.